Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments statistics
85 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.63
- 1.73
- P/OCF Ratio
- 19.16
- 7.17
Enterprise valuationIndustry
- EV / Sales
- 0.83
- 0.96
- EV / EBIT
- 181.95
- 13.35
- EV / FCF
- 17.13
- 7.18
Share statisticsIndustry
- Shares Change (YoY)
- 6.92%
- -1.32%
- Float
- 406M
- 57M
- Shares Held by Insiders
- 23.5%
- 3.33%
- Shares Held by Institutions
- 27.5%
- 84.6%
Short sellingIndustry
- Short Interest
- 23M
- –
- Short Interest Change
- -11.3%
- -2.56%
- Short % of Float
- 5.67%
- 3.81%
- Short % of Shares Outstanding
- 4.34%
- 3.02%
- Days to Cover
- 6.73
- 4.05
Stock price statisticsIndustry
- 52-Week High
- $5.59
- –
- 52-Week Low
- $1.58
- –
- 20-Day Moving Average
- $4.65
- –
- 50-Day Moving Average
- $4.59
- –
- 200-Day Moving Average
- $3.64
- –
- Average True Range (14)
- $0.28
- –
- Price Change (1 Week)
- 8.93%
- 0.12%
- Price Change (1 Month)
- 1.88%
- 4.24%
- Price Change (3 Months)
- 6.09%
- 0.69%
- Price Change (6 Months)
- 39.8%
- 11.5%
- Price Change (YTD)
- 107.7%
- 8.44%
- Price Change (1 Year)
- 91.4%
- 9.87%
- Price Change (3 Years)
- 442.6%
- 49.0%
- Price Change (5 Years)
- -31.8%
- 41.8%
- Average Volume (10 Days)
- 6M
- –
- Average Volume (20 Days)
- 5M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 0.94
- 0.78
- Relative Strength Index (14)
- 56.6
- 55.8
- Volatility (1 Year)
- 59.5%
- 28.3%
- Beta (5 Years)
- 1.66
- 0.60
MarginsIndustry
- EBITDA Margin
- 0.46%
- 13.5%
- FCF Margin
- 4.83%
- 18.5%
Returns on capitalIndustry
- Return on Equity (ROE)
- 3.40%
- 13.9%
- Return on Assets (ROA)
- 1.90%
- 2.97%
- Return on Invested Capital (ROIC)
- 9.64%
- 17.9%
- Return on Capital Employed (ROCE)
- 3.05%
- 5.44%
Financial positionIndustry
- Current Ratio
- 1.55
- 1.47
- Quick Ratio
- 0.94
- 0.97
GrowthIndustry
- Revenue Growth (YoY)
- 54.5%
- 6.46%
- Revenue Growth (3Y CAGR)
- 20.6%
- 9.53%
- Revenue Growth (5Y CAGR)
- 23.4%
- 8.29%
EfficiencyIndustry
- Asset Turnover
- 4.17
- 0.27
- Revenue Per Employee
- $3.78M
- $1.80M
- Profits Per Employee
- $17.20K
- $182.48K
- Employee Count
- 724
- 1,341
- WACC
- 13.2%
- 7.87%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $326.64M
- $331.32M
- Net Cash Per Share
- $0.61
- $5.43
- Equity (Book Value)
- $390.87M
- $3.44B
- Book Value Per Share
- $0.74
- $37.80
- Tangible Book Value
- $390.87M
- $2.32B
- Working Capital
- $189.16M
- $489.26M
Cash flow (TTM)Industry
- Capital Expenditures
- -$3.03M
- -$9.40M
- FCF Per Share
- $0.25
- $8.18
Dividends and yieldsIndustry
- Earnings Yield
- 0.48%
- 8.74%
- FCF Yield
- 5.10%
- 11.6%
- Buyback Yield
- 0.00%
- 3.22%
- Shareholder Yield
- 0.00%
- 4.27%
Scores and fair valueIndustry
- Graham Number
- $0.41
- $76.72
- Graham Upside
- -91.7%
- 11.1%
- Altman Z-Score
- 4.14
- 0.94
- Piotroski F-Score
- 3
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLOV | S&P 500 | Difference | CLOV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +2.1% | -2.7% | +4.8 pts | ||
| 3 months | +7.5% | -1.7% | +9.2 pts | ||
| Year to date | +107.7% | +11.9% | +95.8 pts | ||
| 1 year | +94.4% | +12.0% | +82.4 pts | ||
| 3 years | +440.4% | +78.2% | +362.2 pts | +75.5% | +21.2% |
| 5 years | -31.8% | +73.2% | −105.1 pts | -7.4% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
23M CLOV shares were sold short on Oct 30, 2026, down 11.3% from the previous report, or 5.67% of the shares available to trade. At recent volumes it would take 6.7 days to buy them back. Over the last 20 sessions, 37.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 23,025,747 | -11.3% | 3,422,422 | 6.7 |
| Oct 15, 2026 | 25,949,084 | +13.3% | 4,861,140 | 5.3 |
| Sep 30, 2026 | 22,900,620 | -2.3% | 3,632,140 | 6.3 |
| Sep 15, 2026 | 23,446,183 | -1.0% | 4,530,322 | 5.2 |
| Aug 31, 2026 | 23,677,399 | -9.4% | 3,446,264 | 6.9 |
| Aug 14, 2026 | 26,142,886 | -7.4% | 5,247,010 | 5.0 |
| Jul 31, 2026 | 28,237,098 | -1.8% | 3,932,455 | 7.2 |
| Jul 15, 2026 | 28,748,883 | +29.6% | 5,876,749 | 4.9 |
| Jun 30, 2026 | 22,184,648 | -10.7% | 7,916,464 | 2.8 |
| Jun 15, 2026 | 24,851,129 | -13.1% | 9,964,417 | 2.5 |
| May 29, 2026 | 28,596,652 | -23.5% | 8,252,151 | 3.5 |
| May 15, 2026 | 37,391,816 | -4.4% | 8,128,046 | 4.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?